the webinar seems to be consistent with the presentation given by Auscann recently. Ido made is very clear that they won't be commercialising any novel drugs as this takes 10-15 years and $200m dollars. So this does leave the question if his plan is purely to create drug delivery technology of a "hard shell capsule", does this have any value?
- Forums
- ASX - By Stock
- AC8
- Ann: AusCann Investor Webinar Recording
Ann: AusCann Investor Webinar Recording, page-4
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.62M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AC8 (ASX) Chart |
Day chart unavailable